HOME
>
臨床医学：一般
>
放射線/核医学
> 皆伝！　IVRの知恵　第2版

皆伝！　IVRの知恵　第2版

出版社：	金芳堂
著者：	佐藤守男河合信行(編)
発行日：	2018-10-10
分野：	臨床医学：一般 > 放射線/核医学
ISBN：	9784765317566
電子書籍版：	2018-10-10 （第2版第1刷）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

10,120 円(税込)

購入する

電子書籍

章別単位での購入はできません

ブラウザ、アプリ閲覧

10,120 円(税込)

購入する

商品紹介

2015年日本医学放射線学会総会で大好評につき完売した「伝えたい IVRの知恵」がパワーアップして待望の改訂！日進月歩で進化するIVRの最新の情報を追加し、著者らの斬新な創意工夫をさらに充実。IVRの新定番マニュアル、ここに完成。

目次

1 胸部のIVR
2 消化管のIVR
4 動注化学療法
5 膵・脾のIVR
6 腎臓・副腎のIVR
7 骨盤・大動脈・四肢・頭頚部のIVR
８血管奇形のIVR
９内臓動脈瘤のIVR
10 胸部腹部大動脈のIVR
11 動脈閉塞性病変のIVR
12 門脈のIVR
13 静脈のIVR
14 非血管系のIVR
15 放射線治療とIVR
16 塞栓物質
17 カラーナビゲーション

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

7 骨盤・大動脈・四肢・頭頸部のIVR

P.146 掲載の参考文献

1) Okuno Y, et al. Transcatheter arterial embolization using imipenem / cilastatin sodium for tendinopathy and enthesopathy refractory to non-surgical management. J Vasc Interv Radiol 2013 ; 24 : 787-792.

2) Okuno Y, et al. Short-term results of transcatheter arterial embolization for abnormal neovessels in patients with adhesive capsulitis : a pilot study. J Shoulder Elbow Surg 2014 ; 23 : e199-206.

9 内臓動脈瘤のIVR

P.174 掲載の参考文献

1) Alfredo C. Cordova. Visceral artery aneurysms and pseudoaneurysms-Should they all be managed by endovascular techniques? Ann Vasc Dis 2013 ; 6 : 687-693.

2) Tulsyan N, et al. The endovascular management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg 2007 ; 45 : 276-283.

3) Al-Wahbi AM. Giant celiac artery aneurysm : Treatment by transcatheter coil embolization. Int J Surg Case Rep 2011 ; 2 : 191-193.

4) Pasha SF, et al. Splanchnic artery aneurysms. Mayo Clin Proc 2007 ; 82 : 472-479.

5) Rama Krishnan R, et al. CT imaging findings and endovascular management of isolated spontaneous dissecting aneurysm of celiac artery. Indian J Radiol Imaging 2013 ; 23 : 234-237.

6) Dawson J, Fitridge R. Update on aneurysm disease : Current insights and controversies : Peripheral aneurysms : When to intervene-is rupture really a danger? Prog Cardiovasc Dis 2013 ; 56 : 26-35.

P.177 掲載の参考文献

1) Lorelli DR, et al. Diagnosis and management of aneurysms involving the superior mesenteric artery and its branches-a report of four cases. Vasc Endovascular Surg 2003 ; 37 : 59-66.

2) Blumenberg RM, et al. Abdonlinal apoplexy due to rupture of a superior mesenteric artery aneurysm. Arch Surg 1974 ; 108 : 223-226.

3) Stone WM, et al. Superior mesenteric artery aneurysms : Is presence an indication for intervention? J Vasc Surg 2002 ; 36 : 234-237.

4) Sachdev U, et al. Management of aneurysms involving branches of the celiac and superior mesenteric arteries : a comparison of surgical and endovascular therapy. J Vasc Surg 2006 ; 44 : 718-724.

5) Ikoma A, et al. Inferior pancreaticoduodenal artery aneurysm treated with coil packing and stent placement. World J Radiol 2012 ; 28 : 387-390.

6) Nakai M, et al. Endovascular stenting and stent-graft repair of a hemorrhagic superior mesenteric artery pseudoaneurysm and dissection associated with pancreaticoduodenectomy. J Vasc Interv Radiol 2012 ; 23 : 1381-1384.

P.180 掲載の参考文献

1) Upchurch GR Jr, et al. Splanchnic arteryaneurysms. Vascular Surgery, 6th ed. Rutherford RB ed. Philadelphia, New York : WB Saunders, 2005:1565-1581.

2) Sutton D. Coeliac stenosis or occlusion with aneurysm of the collateral supply. Clin Radiol 1973 ; 24 : 49-53.

3) Paterson GB, et al. Coil embolization of an inferior pancreaticoduodenal artery aneurysm associated with celiac artery occulusion. Cardiovasc Surg 2003 ; 11 : 515-519.

4) Ikeda O, et al. Coil embolization of pancreaticoduodenal artery aneurysms associated with celiac artery stenosis : report of three cases. Cardiovasc Intervent Radiol 2007 ; 30 : 504-507.

5) Ogino H, et al. Embolization in a patients with ruptured anterior inferior pancreaticoduodenal arterial aneurysm with median arcuate ligament. Cardiovasc Intervent Radiol 2002 ; 25 : 318-319.

6) Kobayashi T, et al. Successful trascatheter arterial embolization of an inferior pancreaticoduodenal artery aneurysm associated with celiac axis stenosis. J Gastroenterol Hepatol 2004 ; 19 : 599-601.

7) Ikoma A, et al. Inferior pancreaticoduodenal artery aneurysm treated with coil packing and stent placement. World J Radiol 2012 ; 28 : 387-390.

8) Paty PSK, et al. Aneurysms of the pancreaticoduodenal artery. J Vasc Surg 1996 ; 23 : 710-713.

9) 大石康, 他. 正中弓状靭帯圧迫症候群による背側膵動脈瘤の1例. 日本臨床外科学会会誌 2008 ; 69 : 2649-2655.

10) 山口方規, 他 : 正中弓状靭帯圧迫症候群に伴う膵十二指腸動脈瘤破裂の1例. 日本救急医学会会誌 2010 ; 21 : 257-262.

P.183 掲載の参考文献

1) Bradley EL, et al. The natural history of pancreatic pseudocysts :a unified concept of management. Am J Surg 1979 ; 137 : 135-141.

2) De Perrot M, et al. Management of bleeding pseudoaneurysms in patients with pancreatitis. Br J Surgery 1999 ; 86 : 29-32.

3) Boudghene F, et al. Arterial complications of pancreatitis : diagnostic and therapeutic aspects in 104 cases. J Vasc Interv Radiol 1993 ; 4 : 551-558.

4) Stanley JC. Splenic artery aneurysm. Arch Surg 1970 ; 101 : 689-697.

10 胸部腹部大動脈のIVR

P.188 掲載の参考文献

1) 大木隆生 (編) : 腹部大動脈瘤ステントグラフト内挿術の実際. 医学書院, 2010.

2) EVAR Trial Participants : Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1) : randomized controlled trial. Lancet 2005 ; 365 : 2179-2186.

3) EVAR Trial Participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2) : randomized controlled trial. Lancet 2005 ; 365 : 2187-2192.

4) Nakai M, et al. Midterm results of endovascular abdominal aortic aneurysm repair : comparison of instruction-foruse (IFU) cases and non-IFU cases. Jpn J Radiol 2013 ; 31 ; 585-592.

5) Nakai M, et al. Clinical significance of endoleaks characterized by computed tomography during aortography performed immediately after endovascular abdominal aortic aneurysm repair : prediction of persistent endoleak. Jpn J Radiol 2013 ; 31 (1) 16-23.

6) Nakai M, et al. The use of technetium-99m-labeled human serum albumin diethylenetriamine pentaacetic acid single-photon emission CT scan in the follow-up of type II endoleak treatment. J Vasc Interv Radiol 2014 ; 25 : 405-409.

7) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告)

8) 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版)

P.197 掲載の参考文献

1) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告) 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). 2011.

2) Mitchell RS, et al. First International Summit on Thoracic Aortic Endografting : roundtable on thoracic aortic dissection as an indication for endografting. J Endovasc Ther 2002 ; 9 : II 98-105.

3) Fukui D, et al. Innovative application of available stent grafts in Japan in aortic aneurysm treatment-significance of innovative debranching and chimney method and coil embolization procedure. Ann Vasc Dis 2013 ; 6 : 601-611.

4) Makaroun MS, et al. Endovascular treatment of thoracic aortic aneurysms : results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J Vasc Surg 2005 ; 41 : 1-9.

5) Yoshida RA, et al. Total endovascular debranching of the aortic arch. Eur J Vasc Endovasc Surg 2001 ; 42 : 627-630.

6) Cires G, et al. Endovascular debranching of the aortic arch during thoracic endograft repair. J Vasc Surg 2011 ; 53 : 1485-1491.

7) Sugiura K, et al. The applicability of chimney grafts in the aortic arch. J Cardiovasc Surg (Torino) 2009 ; 50 : 475-481.

8) Ohrlander T, et al. The chimney graft : a technique for preserving or rescuing aortic branch vessels in stent-graft sealing zones. J Endovasc Ther 2008 ; 15 : 427-432.

11 動脈閉塞性病変のIVR

P.206 掲載の参考文献

1) Dormandy JA, Rutherford RB. TASC working group : management of peripheral arterial disease (PAD). TransAtlantic inter-society consensus (TASC). J Vasc Surg 2000 ; 31 : S1-S296.

2) Norgren L, Hiatt WR, et al. Inter-society consensus for the management of peripheral artery disease (TASC II). J Vasc Surg 2007 ; 45 (Suppl) : S147-S157.

3) 佐藤守男, 他. 下肢動脈の長区間閉塞に対する迅速大量ウロキナーゼ投与法について. 日本医放会誌 1986 ; 46 : 1001-1006.

4) Toshima M, et al. Catheter-directed thrombolytic therapy for acute native arterial occlusion-comparison with surgical therapy. Jpn. J Vasc Surg 2000 ; 9 : 491-497.

5) Ouriel K, et al. A comparison of thrombolytic therapy with operative vascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994 ; 19 : 1021-1030.

P.210 掲載の参考文献

1) Schoots IG, et al. Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol 2005 ; 16 : 317-329.

2) Ryer EJ, et al. Revascularization for acute mesenteric ischemia. J Vasc Surg 2012 ; 55 : 1682-1689.

3) Block TA, et al. Endovascular and open surgery for acute occlusion of the superior mesenteric artery. J Vasc Surg 2010 ; 52 : 959-966.

4) Jamieson AC, et al. Lysis of a superior mesenteric artery embolus following local infusion of streptokinase and heparin. Aust N Z J Surg 1979 ; 49 : 355-356.

5) Ogihara S, et al. Superior mesenteric arterial embolism : treatment by trans-catheter thrombo-aspiration. J Gastroenterol 2003 ; 38 : 272-277.

6) Kawarada O, et al. Direct aspiration using rapid-exchange and low-profile device for acute thromboembolic occlusion of the superior mesenteric artery. Cathet Cardiovasc Interv 2006 ; 68 : 862-866.

7) Sonoda K, et al. Successful treatment of acute occlusion in superior mesenteric artery of an elderly man by thrombus aspiration. J Clin Gastroenterol 2007 ; 41 : 933-934.

8) Heiss P, et al. Primary percutaneous aspiration and thorombolysis for the treatment of acute embolic superior mesenteric artery occlusion. Eur Radiol 2010 ; 20 : 2948-2958.

9) Kawasaki R, et al. Aspiration therapy for acute superior mesenteric artery embolism with an angled guiding sheath and guiding catheter. J Vasc Interv Radiol 2014 ; 25 : 635-639.

10) 園村哲郎, 他. 急性腹症の画像診断 : 血管性病変, 急性胃腸炎, 消化管穿孔による急性腹症. 画像診断 2007 ; 27 : 326-334.

P.213 掲載の参考文献

1) Derrick JR, et al. The pattern of arteriosclerotic narrowing of the celiac and superior mesenteric arteries. Ann Surg 1959 ; 149 : 684-689.

2) AbuRahma AF, et al. Angioplasty/stenting of the superior mesenteric artery and celiac trunk : early and late outcomes. J Endovasc Ther 2003 ; 10 : 1046-1053.

3) Loomer DC, et al. Superior mesenteric artery stent placement in a patient with acute mesenteric ischemia. J Vasc Interv Radiol 1999 ; 10 : 29-32.

4) Socrate AM, et al. Aortic dissection after superior mesenteric artery percutaneous stenting. Case report. Minerva Cardioangiol 2000 ; 48 : 89-94.

P.215 掲載の参考文献

1) Pulli R, et al. Early and long-term comparison of endovascular treatment of iliac artery occlusions and stenosis. J Vasc Surg 2011 ; 53 : 92-98.

2) Dattilo PB, et al. Clinical outcomes with contemporary endovascular therapy of iliac artery occlusive disease. Catheter Cardiovasc Interv 2012 ; 80 : 644-654.

3) Chen BL, et al. Subintimal angioplasty of chronic total occlusion in iliac arteries : a safe and durable option. J Vasc Surg 2011 ; 53 : 367-373.

4) Schmieder GC, et al. Selective stenting in subintimal angioplasty : analysis of primary stent outcomes. J Vasc Surg 2008 ; 48 : 1175-1180 ; discussion 1180-1181.

5) Carnevale FC, et al. Percutaneous endovascular treatment of chronic iliac artery occlusion. Cardiovasc Intervent Radiol 2004 ; 27 : 447-452.

6) Ye W, et al. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011 ; 53 : 1728-1737.

7) Timaran CH, et al. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003 ; 38 : 272-278.

8) Leville CD, et al. Endovascular management of iliac artery occlusions : extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. Vasc Surg 2006 ; 43 : 32-39.

P.220 掲載の参考文献

1) Kralj I, Boos I, et al. Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions-a single-center outcome analysis of a subcohort of MISAGO 2 study. Vasa 2013 ; 42 : 340-349.

2) Malas MB, Enwerem N, et al. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease. J Vasc Surg 2014 ; 59 : 129-135.

3) Davaine JM, Querat J, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. Eur J Vasc Endovasc Surg 2013 ; 46 : 201-212.

4) Katsanos K, Tepe G, et al. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol 2014 ; 11.

5) Grenville JL, Tan KT, et al. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease : Mid-term outcomes from a single tertiary referral center. Vascular 2014 ; 2.

6) Armstrong EJ, Singh S, et al. Angiographic characteristics of femoropopliteal in-stent restenosis : association with long-term outcomes after endovascular intervention. Catheter Cardiovasc Interv 2013 ; 82 : 1168-1174.

7) Deloose K, Lauwers K, et al. Drug-eluting technologies in femoral artery lesions. J Cardiovasc Surg (Torino) 2013 ; 54 : 217-224. GORE VIABAHNGORE VIABAHNGORE VIABAHN

P.224 掲載の参考文献

1) Romiti M, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008 ; 47 : 975-981.

2) Casella IB, et al. Outcome analysis of infrapopliteal percutaneous transluminal angioplasty and bypass graft surgery with nonreversed saphenous vein for individuals with critical limb ischemia. Vasc Endovascular Surg 2010 ; 44 : 625-632.

3) Schamp KB, et al. The ongoing battle between infrapopliteal angioplasty and bypass surgery for critical limb ischemia. Ann Vasc Surg 2012 ; 26 : 1145-1153.

4) Conrad MF, et al. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg 2009 ; 50 : 799-805. e4.

5) Randon C, et al. Angioplasty or primary stenting for infrapopliteal lesions : results of a prospective randomized trial. Cardiovasc Intervent Radiol 2010 ; 33 : 260-269.

6) Rana MA, Gloviczki P. Endovascular interventions for infrapopliteal arterial disease : an update. Semin Vasc Surg 2012 ; 25 : 29-34.

7) Donas KP, et al. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up. J Vasc Surg 2010 ; 52 : 356-361.

13 静脈のIVR

P.297 掲載の参考文献

1) Decousus H, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998 ; 12 : 409-415.

2) PREPIC study group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism : the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005 ; 112 : 416-422.

3) Mismetti P, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism : a randomized clinical trial. JAMA 2015 ; 313 : 1627-1635.

P.309 掲載の参考文献

1) O'Sullivan GJ, et al. Endovascular management of iliac vein compression (May-Thurner) syndrome. JVIR 2000 ; 11 : 823-836.

P.317 掲載の参考文献

1) Zuckerman AM, et al. Percutaneous Varicocele Occlusion : Long-term Follow-up. JVIR 1994 ; 5 : 315-319.

2) Dewire DM, et al. Clinical outcome and cost comparison of percutaneous embolization and surgical ligation of varicocele. J Androl 1994 : 15 : 38-42.

15 放射線治療とIVR

P.380 掲載の参考文献

1) Szmuness W. Hepatocellular carcinoma and the hepatitis B virus : evidence for a causal association. Prog Med Virol 1978 ; 24 : 40-69.

2) Ikai I et al. Surgical intervention for patients with stage IV-A hepato-cellular carcinoma without lymph node metastasis : proposal as a standard therapy. Ann Surg 1998 ; 227 : 433-439.

3) Kaibori M, et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med 2011 ; 25 : 593-602.

4) Llovet JM, et al. Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma : a randomised controlled trial. Lancet 2002 ; 359 (9319) : 1734-1739.

5) Lo CM, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 ; 35 : 1164-1171.

6) Nanashima A, et al. Relationship between CT volumetry and functional liver volume using technetium-99m alactosyl serum albumin scintigraphy in patients undergoing preopera-tive portal vein embolization before major hepatectomy : a preliminary study. Dig Dis Sci 2006 ; 51 : 1190-1195.

7) Li JQ, et al. Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 1995 ; 121 : 364-366.

8) Kudo M, et al. Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.Eur J Cancer 2011 ; 47 : 2117-2127.

9) Llovet JM, et al. SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008 ; 359 : 378-390.

10) Cheng AL, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma : a phase III randomized double-blind, placebo-controlled trial. Lancet Oncol 2009 ; 10 : 25-34.

11) Shirai S, et al. The safety indicator of radiotherapy for advanced hepatoma with liver cirrhosis. Journal of Gastroenterology and Hepatology Research 2013 ; 2 : 730-736.

12) Peters NA, et al. Bowel perforation after radio-therapy in a patient receiving sorafenib. J Clin Oncol 2008 ; 26 : 2405-2406.

13) Shirai S, et al. Single photon emission computed tomogra-phy-based three-dimensional conformal radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus. Int J Radiat Oncol Biol Phys 2009 ; 73 : 824-831.

14) Shirai S, et al. Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemo-embolization. Int J Radiat Oncol Biol Phys 2010 ; 76 : 1037-1044.

15) Cheng JC, et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2004 ; 60 : 1502-1509.

16) Liang SX, et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma : the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 2006 ; 65 : 426-434.

17) Choi BO, et al. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.Jpn J Clin Oncol 2006 ; 36 : 154-158.

18) Andolino DL, et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2011 ; 81 : e447-453.

19) Kim TH, et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007 ; 67 : 225-231.

20) Hata M, et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2005 ; 104 : 794-801.

21) Sugahara S, et al. Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2010 ; 76 : 460-466.

22) Sugahara K, et al. Separate analysis of asialoglycopro-tein receptors in the right and left hepatic lobes using Tc-GSA SPECT. Hepatology 2003 ; 38 : 1401-1409.

23) Marks LB, et al. Incorporation of functional status into dose-volume analysis. Med Phys 1999 ; 26 : 196-199.

24) Meng MB, et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma : a systemic review and meta-analysis.Radiother Oncol 2009 ; 92 : 184-194.

25) Park HC, et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma.Int J Radiat Oncol Biol Phys 2002 ; 54 : 150-155.

26) Shirai S, et al. SPECT-based radiation therapy and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma sized 14 cm or greater. Cancer and Clinical Oncology 2012 ; 1 : 65-76.

27) Park W, et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005 ; 61 : 1143-1150.

28) Ishikura S, et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 2002 ; 25 : 189-193.

29) Arata S, et al. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI. Hepatogastroenterology 2001 ; 48 : 480-485.

30) Mohan R, et al. A technique for computing dose volume histograms for structure combinations.Med Phys 1987 ; 14 : 1048-1052.

31) Yamada R, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983 ; 148 : 397-401.

P.391 掲載の参考文献

1) Morton G, et al. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? Radiother Oncol 2011 ; 100 : 463-467.

2) "Advances in Prostate Cancer", book edited by Gerhard Hamilton, ISBN 978-953-51-0932-7, Published : January 16, 2013.

書評

書評を投稿する

最近チェックした商品履歴

Loading...